Beckman Coulter Announces FDA Clearance Of The UniCel(R) DxC 600i Chemistry-Immunoassay System (Medical News Today)
Beckman Coulter, Inc.(NYSE: BEC) announced today that its newest chemistry-immunoassay workstation -- the UniCel DxC 600i Synchron(R) Access(R) clinical system -- has beencleared by the U.S. Food and Drug Administration. The DxC 600i continues the company's strategy of delivering standardizedproduct lines with large onboard test menus for greater workstationconsolidation... click link for more